Claudio Villaquirán Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Claudio Villaquirán Torres has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Andrés Celis Preciado
Faculté de Médecine et des Sciences de la Santé Université de Sherbrooke Sherbrooke Québec Canada
6 shared publications - Juan David Botero Bahamon
Department of Internal Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
3 shared publications - July Vianneth Torres-González
Médico neumólogo. Especialista en epidemiología. Universidad Nacional de Colombia. Bogotá, Colombia
3 shared publications - María José Fernández Sánchez
Hospital Universitario San Ignacio
3 shared publications - Olga Milena García Morales
Internal Medicine Department, Fundación Santafé de Bogotá, Bogotá, Colombia; Andes University Medicine Faculty, Bogotá, Colombia
3 shared publications - Javier Iván Lasso Apráez
Hospital Universitario San Ignacio
2 shared publications
Latest Publications
- Open Access
- 20 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 37 (1) , 38-43
Disfunción de cuerdas vocales como diagnóstico diferencial de una crisis asmática y asma no controlada. Descripción de un caso y revisión de la literatura
Vocal fold dysfunction (VCD) is a pathology characterized by paroxysmal and involuntary episodes of adduction of the vocal folds during inspiration. In severe cases, it obstructs the central airway, causing dyspnea and stridor. This disorder is related to multiple etiologies, such as neurological disorders, gastroesophageal reflux, psychogenic disorders, allergic rhinitis, and asthma, among others. VCD occurs in women between 20 and 45 years of age. However, it also includes preschool children, schoolchildren, and adults. Laryngeal dysfunction can be confused with asthma, acute respiratory disorders, or laryngeal problems. The diagnosis is usually made after excluding other pathologies by performing forced spirometry and direct vision of the paradoxical movement of the vocal folds during inspiration by fiberoptic bronchoscopy (FBC). We present the case of a patient who consulted because of cough, dyspnea, and wheezing refractory to bronchodilator management, where the studies carried out helped to rule out infectious/bronchial obstructive pathology and showed the diagnosis of VCD.
- 20 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 37 (1) , 38-43
Open AccessDisfunción de cuerdas vocales como diagnóstico diferencial de una crisis asmática y asma no controlada. Descripción de un caso y revisión de la literatura
Vocal fold dysfunction (VCD) is a pathology characterized by paroxysmal and involuntary episodes of adduction of the vocal folds during inspiration. In severe cases, it obstructs the central airway, causing dyspnea and stridor. This disorder is related to multiple etiologies, such as neurological disorders, gastroesophageal reflux, psychogenic disorders, allergic rhinitis, and asthma, among others. VCD occurs in women between 20 and 45 years of age. However, it also includes preschool children, schoolchildren, and adults. Laryngeal dysfunction can be confused with asthma, acute respiratory disorders, or laryngeal problems. The diagnosis is usually made after excluding other pathologies by performing forced spirometry and direct vision of the paradoxical movement of the vocal folds during inspiration by fiberoptic bronchoscopy (FBC). We present the case of a patient who consulted because of cough, dyspnea, and wheezing refractory to bronchodilator management, where the studies carried out helped to rule out infectious/bronchial obstructive pathology and showed the diagnosis of VCD.
- Open Access
- 10 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 36 (2Supl-1) , 1-102
Consenso Colombiano en Hipertensión Arterial Pulmonar Recomendaciones basadas en consenso de expertos e informadas en la evidencia para el diagnóstico, tratamiento y seguimiento en hipertensión pulmonar.
Introduction: Pulmonary Arterial Hypertension (PAH) is a clinical condition characterized by dysfunction of the pulmonary arterial endothelium that manifests with increased flow restriction in the pulmonary circulation. Numerous advances have been made in understanding the pathophysiology, risk stratification, treatment, and follow-up of patients with this disease. Among these advances is the update in the hemodynamic definition of the event, which largely determines the therapeutic actions to be followed. Due to the above, it was considered necessary to establish recommendations for managing patients with PAH, based on an approach that considers access, use, and provision of health services in Colombia. Methodology: The final document was developed in six stages: 1. Definition of the research questions and content. 2. Search, screening, selection, and evaluation of the evidence. 3. Preparation of a narrative summary of the evidence-based on the guiding questions. 4. Discussion of findings in formal panels. 5. Formulation of recommendations. 6. Writing and consolidation of the final consensus document. Results: The 34 participants reached a consensus and formulated 26 recommendations based on four thematic segments: i) definitions and diagnostic segment, ii) risk stratification segment, iii) treatment segment and iv) follow-up segment. Conclusion: The formulated recommendations will guide primary care physicians in identifying clinical suspicion of the disease and for specialists and subspecialists in confirming the diagnosis, defining the therapeutic approach, and managing patient follow-up. As new evidence emerges, these recommendations should be carefully reviewed and updated.
- 10 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 36 (2Supl-1) , 1-102
Open AccessConsenso Colombiano en Hipertensión Arterial Pulmonar Recomendaciones basadas en consenso de expertos e informadas en la evidencia para el diagnóstico, tratamiento y seguimiento en hipertensión pulmonar.
Introduction: Pulmonary Arterial Hypertension (PAH) is a clinical condition characterized by dysfunction of the pulmonary arterial endothelium that manifests with increased flow restriction in the pulmonary circulation. Numerous advances have been made in understanding the pathophysiology, risk stratification, treatment, and follow-up of patients with this disease. Among these advances is the update in the hemodynamic definition of the event, which largely determines the therapeutic actions to be followed. Due to the above, it was considered necessary to establish recommendations for managing patients with PAH, based on an approach that considers access, use, and provision of health services in Colombia. Methodology: The final document was developed in six stages: 1. Definition of the research questions and content. 2. Search, screening, selection, and evaluation of the evidence. 3. Preparation of a narrative summary of the evidence-based on the guiding questions. 4. Discussion of findings in formal panels. 5. Formulation of recommendations. 6. Writing and consolidation of the final consensus document. Results: The 34 participants reached a consensus and formulated 26 recommendations based on four thematic segments: i) definitions and diagnostic segment, ii) risk stratification segment, iii) treatment segment and iv) follow-up segment. Conclusion: The formulated recommendations will guide primary care physicians in identifying clinical suspicion of the disease and for specialists and subspecialists in confirming the diagnosis, defining the therapeutic approach, and managing patient follow-up. As new evidence emerges, these recommendations should be carefully reviewed and updated.
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A3266
Usefulness of Lung Ultrasound in the Study of Pulmonary Sarcoidosis
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A3266
Usefulness of Lung Ultrasound in the Study of Pulmonary Sarcoidosis
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A5881
Solitary Fibrous Tumor of the Pleura, the Other Side of the Coin
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A5881
Solitary Fibrous Tumor of the Pleura, the Other Side of the Coin
- Open Access
- 2 June 2022
- Published by VM Media Group sp. z o.o in Palliative Medicine in Practice
- Vol. 16 (2) , 103-107
Use of tunnelled pleural catheter for palliative treatment of malignant pleural effusion: Experience of a third level hospital
Introduction: Pleural effusion is a manifestation of advanced cancer that is associated with symptoms whose control requires adopting different strategies. This study aimed to characterize the population of patients with malignant pleural effusion who underwent placement (or insertion) of a tunnelled pleural catheter to alleviate dyspnoea, describe the experience of its use and evaluate the 30-day hospitalization rate for pleural effusion and the percentage of early and late complications. Patients and methods: This study is a series of cases with cancer taken to implantation of a closed pleural drainage system during the year 2020 in a third level hospital in Colombia. Results: Eight patients underwent this procedure, in whom implantation was successful. Pleural effusion due to breast cancer was the main indication. No late catheter complications were recorded given the high 30-day mortality, despite a low LENT (LDH, ECOG, neutrophilia and tumour type) score in some patients. Conclusions: The indwelling tunnelled pleural catheter is useful in the palliative treatment of malignant pleural effusion with few complications. It is necessary to evaluate the performance of the LENT scale in the study population, given that despite a low score, the 30-day mortality rate was high. Introduction: Pleural effusion is a manifestation of advanced cancer that is associated with symptoms whose control requires adopting different strategies. This study aimed to characterize the population of patients with malignant pleural effusion who underwent placement (or insertion) of a tunnelled pleural catheter to alleviate dyspnoea, describe the experience of its use and evaluate the 30-day hospitalization rate for pleural effusion and the percentage of early and late complications. Patients and methods: This study is a series of cases with cancer taken to implantation of a closed pleural drainage system during the year 2020 in a third level hospital in Colombia. Results: Eight patients underwent this procedure, in whom implantation was successful. Pleural effusion due to breast cancer was the main indication. No late catheter complications were recorded given the high 30-day mortality, despite a low LENT (LDH, ECOG, neutrophilia and tumour type) score in some patients. Conclusions: The indwelling tunnelled pleural catheter is useful in the palliative treatment of malignant pleural effusion with few complications. It is necessary to evaluate the performance of the LENT scale in the study population, given that despite a low score, the 30-day mortality rate was high.
- 2 June 2022
- Published by VM Media Group sp. z o.o in Palliative Medicine in Practice
- Vol. 16 (2) , 103-107
Open AccessUse of tunnelled pleural catheter for palliative treatment of malignant pleural effusion: Experience of a third level hospital
Introduction: Pleural effusion is a manifestation of advanced cancer that is associated with symptoms whose control requires adopting different strategies. This study aimed to characterize the population of patients with malignant pleural effusion who underwent placement (or insertion) of a tunnelled pleural catheter to alleviate dyspnoea, describe the experience of its use and evaluate the 30-day hospitalization rate for pleural effusion and the percentage of early and late complications. Patients and methods: This study is a series of cases with cancer taken to implantation of a closed pleural drainage system during the year 2020 in a third level hospital in Colombia. Results: Eight patients underwent this procedure, in whom implantation was successful. Pleural effusion due to breast cancer was the main indication. No late catheter complications were recorded given the high 30-day mortality, despite a low LENT (LDH, ECOG, neutrophilia and tumour type) score in some patients. Conclusions: The indwelling tunnelled pleural catheter is useful in the palliative treatment of malignant pleural effusion with few complications. It is necessary to evaluate the performance of the LENT scale in the study population, given that despite a low score, the 30-day mortality rate was high. Introduction: Pleural effusion is a manifestation of advanced cancer that is associated with symptoms whose control requires adopting different strategies. This study aimed to characterize the population of patients with malignant pleural effusion who underwent placement (or insertion) of a tunnelled pleural catheter to alleviate dyspnoea, describe the experience of its use and evaluate the 30-day hospitalization rate for pleural effusion and the percentage of early and late complications. Patients and methods: This study is a series of cases with cancer taken to implantation of a closed pleural drainage system during the year 2020 in a third level hospital in Colombia. Results: Eight patients underwent this procedure, in whom implantation was successful. Pleural effusion due to breast cancer was the main indication. No late catheter complications were recorded given the high 30-day mortality, despite a low LENT (LDH, ECOG, neutrophilia and tumour type) score in some patients. Conclusions: The indwelling tunnelled pleural catheter is useful in the palliative treatment of malignant pleural effusion with few complications. It is necessary to evaluate the performance of the LENT scale in the study population, given that despite a low score, the 30-day mortality rate was high.
- Open Access
- 15 July 2021
- Published by Instituto Nacional de Cancerologia in Revista Colombiana de Cancerología
- Vol. 26 (1) , 14-21
Catéter pleural permanente una opción para el manejo del derrame pleural maligno
Revisión narrativa sobre como el cáncer altera la fisiología de la pleura, como se estudia el derrame pleural maligno y como se puede brindar paliación manejo del paciente con derrame pleural con el catéter pleural permanente o tunelizado cuyo uso demuestra mayores beneficios en diferentes ámbitos clínicos, siendo utilizado principalmente para el tratamiento del derrame pleural tumoral recurrente pero también en algunos casos de derrame pleural benigno recurrente haciéndolo un recurso útil en cáncer avanzado.
- 15 July 2021
- Published by Instituto Nacional de Cancerologia in Revista Colombiana de Cancerología
- Vol. 26 (1) , 14-21
Open AccessCatéter pleural permanente una opción para el manejo del derrame pleural maligno
Revisión narrativa sobre como el cáncer altera la fisiología de la pleura, como se estudia el derrame pleural maligno y como se puede brindar paliación manejo del paciente con derrame pleural con el catéter pleural permanente o tunelizado cuyo uso demuestra mayores beneficios en diferentes ámbitos clínicos, siendo utilizado principalmente para el tratamiento del derrame pleural tumoral recurrente pero también en algunos casos de derrame pleural benigno recurrente haciéndolo un recurso útil en cáncer avanzado.
- Open Access
- 30 August 2020
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 61 (4)
Fibrosis pulmonar en infección por SARSCoV- 2: ¿qué sabemos hasta ahora? ¿Qué podemos esperar?
La infección por SARS-CoV-2 le ha traído grandes retos al personal de salud durante 2020. Aprender sobre su comportamiento, fisiopatología, afectación pulmonar y su progresión a síndrome de dificultad respiratoria aguda (SDRA), además de las intervenciones farmacológicas y la mortalidad, han representado un desafío científico en los centros de atención especializada. No obstante, y a pesar de los avances sobre la infección aguda, poco se conoce respecto a las potenciales secuelas posteriores a la infección leve, moderada o severa por SARS-CoV-2, entre ellas la posible afectación fibrosante del parénquima pulmonar, que de acuerdo con la experiencia sobre infecciones por otros coronavirus (síndrome respiratorio agudo severo y síndrome respiratorio de Oriente Medio) y otras causas de SDRA, puede ser una de las complicaciones más severas y con mayor impacto en la calidad de vida y en la funcionalidad de las personas, una vez superada la infección. En este artículo se revisa la evidencia disponible sobre el desarrollo de la enfermedad pulmonar intersticial de tipo fibrosante asociada con la infección por SARS-CoV-2, los posibles mecanismos fisiopatológicos, los hallazgos imagenológicos y el plan de manejo propuesto hasta el momento, especialmente en términos de rehabilitación integral de estos pacientes.
- 30 August 2020
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 61 (4)
Open AccessFibrosis pulmonar en infección por SARSCoV- 2: ¿qué sabemos hasta ahora? ¿Qué podemos esperar?
La infección por SARS-CoV-2 le ha traído grandes retos al personal de salud durante 2020. Aprender sobre su comportamiento, fisiopatología, afectación pulmonar y su progresión a síndrome de dificultad respiratoria aguda (SDRA), además de las intervenciones farmacológicas y la mortalidad, han representado un desafío científico en los centros de atención especializada. No obstante, y a pesar de los avances sobre la infección aguda, poco se conoce respecto a las potenciales secuelas posteriores a la infección leve, moderada o severa por SARS-CoV-2, entre ellas la posible afectación fibrosante del parénquima pulmonar, que de acuerdo con la experiencia sobre infecciones por otros coronavirus (síndrome respiratorio agudo severo y síndrome respiratorio de Oriente Medio) y otras causas de SDRA, puede ser una de las complicaciones más severas y con mayor impacto en la calidad de vida y en la funcionalidad de las personas, una vez superada la infección. En este artículo se revisa la evidencia disponible sobre el desarrollo de la enfermedad pulmonar intersticial de tipo fibrosante asociada con la infección por SARS-CoV-2, los posibles mecanismos fisiopatológicos, los hallazgos imagenológicos y el plan de manejo propuesto hasta el momento, especialmente en términos de rehabilitación integral de estos pacientes.
- Open Access
- 7 May 2020
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 61 (3)
Informe - COVID-19
- 7 May 2020
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 61 (3)
Open AccessInforme - COVID-19